Residual macrovascular risk in 2013: what have we learned? (2014)
- Authors:
- Fruchart, Jean-Charles
- Davignon, Jean
- Hermans, Michel P.
- Al-Rubeaan, Khalid
- Amarenco, Pierre
- Assmann, Gerd
- Barter, Philip
- Betteridge, John
- Bruckert, Eric
- Cuevas, Ada
- Farnier, Michel
- Ferrannini, Ele
- Fioretto, Paola
- Genest, Jacques
- Ginsberg, Henry N.
- Gotto, Antonio M.
- Hu, Dayi
- Kadowaki, Takashi
- Kodama, Tatsuhiko
- Krempf, Michel
- Matsuzawa, Yuji
- Núñez-Cortés, Jesús
- Monfil, Carlos
- Ogawa, Hisao
- Plutzky, Jorge
- Rader, Daniel J.
- Sadikot, Shaukat
- Santos, Raul D.
- Shlyakhto, Evgeny
- Sritara, Piyamitr
- Sy, Rody
- Tall, Alan
- Tan, Chee Eng
- Tokgözoğlu, Lale
- Toth, Peter P.
- Valensi, Paul
- Wanner, Christoph
- Zambon, Alberto
- Zhu, Junren
- Zimmet, Paul
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1186/1475-2840-13-26
- Subjects: FATORES DE RISCO; SISTEMA CARDIOVASCULAR (ANORMALIDADES); DISLIPIDEMIAS; DIABETES MELLITUS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Cardiovascular Diabetology
- ISSN: 1475-2840
- Volume/Número/Paginação/Ano: v. 13, n. 26, 17 p. (on-line), 2014
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
FRUCHART, Jean-Charles; DAVIGNON, Jean; HERMANS, Michel P.; et al. Residual macrovascular risk in 2013: what have we learned? Cardiovascular Diabetology, London, v. 13, n. 26, p. 17 (on-line), 2014. Disponível em: < http://www.cardiab.com/content/pdf/1475-2840-13-26.pdf > DOI: 10.1186/1475-2840-13-26. -
APA
Fruchart, J. -C., Davignon, J., Hermans, M. P., Al-Rubeaan, K., Amarenco, P., Assmann, G., et al. (2014). Residual macrovascular risk in 2013: what have we learned? Cardiovascular Diabetology, 13( 26), 17 (on-line). doi:10.1186/1475-2840-13-26 -
NLM
Fruchart J-C, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés J, Monfil C, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P. Residual macrovascular risk in 2013: what have we learned? [Internet]. Cardiovascular Diabetology. 2014 ; 13( 26): 17 (on-line).Available from: http://www.cardiab.com/content/pdf/1475-2840-13-26.pdf -
Vancouver
Fruchart J-C, Davignon J, Hermans MP, Al-Rubeaan K, Amarenco P, Assmann G, Barter P, Betteridge J, Bruckert E, Cuevas A, Farnier M, Ferrannini E, Fioretto P, Genest J, Ginsberg HN, Gotto AM, Hu D, Kadowaki T, Kodama T, Krempf M, Matsuzawa Y, Núñez-Cortés J, Monfil C, Ogawa H, Plutzky J, Rader DJ, Sadikot S, Santos RD, Shlyakhto E, Sritara P, Sy R, Tall A, Tan CE, Tokgözoğlu L, Toth PP, Valensi P, Wanner C, Zambon A, Zhu J, Zimmet P. Residual macrovascular risk in 2013: what have we learned? [Internet]. Cardiovascular Diabetology. 2014 ; 13( 26): 17 (on-line).Available from: http://www.cardiab.com/content/pdf/1475-2840-13-26.pdf - Efeitos da sinvastatina no perfil lipidico e na remocao plasmatica de uma emulsao lipidica semelhante a lipoproteina de baixa densidade (ldl) em pacientes hipercolesterolemicos
- Principais dislipidemias, risco cardiovascular e seu tratamento
- Tratamento das dislipidemias
- Recommendations for the management of patients with familial hypercholesterolemia
- Relation of Physical Activity to Prevalence of Nonalcoholic Fatty Liver Disease Independent of Cardiometabolic Risk
- Como avaliar um novo marcador de risco para a aterosclerose
- Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel
- Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)
- Mipomersen preferentially reduces small low-density lipoprotein particle number in patients with hypercholesterolemia
- Cascade Screening in Familial Hypercholesterolemia: Advancing Forward
Informações sobre o DOI: 10.1186/1475-2840-13-26 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
